VISIUM TECHNOLOGIES, INC.
A financially distressed OTC stock characterized by massive interest obligations, no reported revenue, and a significant accumulated deficit.
A financially distressed OTC stock characterized by massive interest obligations, no reported revenue, and a significant accumulated deficit.
An aggressive investor might buy VISM if they believe the current assets of $67k can be liquidated to settle the $5.9M liabilities, potentially leaving equity value upon restructuring. The positive financing cash flow indicates ongoing efforts to raise capital or refinance debt, which could stabilize the balance sheet.
Avoid this stock due to a retained earnings deficit of $64.1M and zero revenue, indicating no product-market fit or successful commercial operations. The negative net profit in 2023 and 2025 combined with high interest expenses creates a unsustainable financial trajectory without immediate cash infusion.
VISIUM TECHNOLOGIES, INC. (VISM) is an OTC-traded entity with minimal revenue but significant cash flow financing activities. The company reports substantial interest expenses against negligible operating revenues, suggesting a capital-intensive structure or distressed financial state. Key metrics include a retained earnings deficit of $64.1M and recent net losses in 2025.
The company recently shifted from a 2024 profit of $2.9M back to a $1.3M loss in 2025, signaling operational instability. While financing cash flows remain positive at $462M, the negative operating cash flow and massive interest expense suggest the business model is not yet self-sustaining without external capital injections.
The company operates in a niche OTC environment where many firms struggle with liquidity and solvency before achieving profitability. With no revenue reported, the firm likely faces intense competition from established players who can generate cash flow from operations to service debt and invest in growth.
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| Operating Expenses | $2.4M | $2.6M | $1.7M |
| Operating Income | $-2.4M | $-2.6M | $-1.7M |
| R&D | $215.0K | $86.7K | $325 |
| G&A | $0 | $0 | $0 |
| Stock-Based Comp | $856.5K | $1.2M | — |
| Other OpEx | $2.2M | $2.5M | $1.6M |
| Non-Operating Income | $0 | $0 | $308.2K |
| Interest Expense | $334.8K | $307.6K | $463.4K |
| Pre-Tax Income | $-2.4M | $-2.6M | $-1.3M |
| Income Tax | $0 | $0 | $0 |
| Continuing Ops | $-2.4M | $-2.6M | $-1.3M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-3.3M | $2.9M | $-1.3M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-3.3M | $2.9M | $-1.3M |
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Current Assets | $10.0K | $8.5K | $67.6K |
| Cash & Equivalents | $10.0K | — | — |
| Other Current Assets | $0 | — | — |
| Long-Term Assets | $0 | $0 | $0 |
| Total Assets | $10.0K | $8.5K | $67.6K |
| Current Liabilities | $4.3M | $5.2M | $5.9M |
| Long-Term Liabilities | $0 | $0 | $0 |
| Total Liabilities | $4.3M | $5.2M | $5.9M |
| Shareholders' Equity | $-4.3M | $-5.1M | $-5.8M |
| Paid-In Capital | $55.6M | $57.6M | $58.2M |
| Retained Earnings | $-59.9M | $-62.7M | $-64.1M |
| Total L&E | $10.0K | $8.5K | $67.6K |
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net Income (CFO) | $-3.3M | $2.9M | $-1.3M |
| Non-Cash Adjustments | $1.5M | $-4.5M | $-315.3K |
| Working Capital Changes | $1.3M | $1.1M | $1.2M |
| Cash from Operations | $-523.9K | $-488.3K | $-411.2K |
| Cash from Investing | $0 | $0 | $0 |
| Cash from Financing | $396.9K | $486.8K | $462.9K |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $-127.0K | $-1.5K | $51.7K |
| Beginning Cash | $137.0K | $10.0K | $8.5K |
| Ending Cash | $10.0K | $8.5K | $60.1K |
The company appears to have no identifiable operating business segments generating revenue as the cost of revenue is zero. All financial activity revolves around financing cash flows totaling $462M and high interest expenses of $463k, indicating potential debt restructuring or holding status rather than active product sales.
1) Severe liquidity risk with operating cash flows of -$411k and a net profit loss of $1.3M for 2025. 2) High solvency risk indicated by current liabilities of $5.9M exceeding current assets of $67k, resulting in negative shareholders' equity of $5.8M. 3) Inability to service debt evidenced by interest expense of $463k with no operating income to cover it.
Primary advantages are limited to existing paid-in capital of $58.2M which provides a buffer against immediate insolvency despite the deficit. The company has zero long-term liabilities, offering flexibility in restructuring obligations if assets are liquidated.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.